Jens Juul Holst
From Wikipedia, the free encyclopedia
Jens Juul Holst | |
|---|---|
| Born | 31 August 1945 Copenhagen, Denmark |
| Alma mater | University of Copenhagen |
| Scientific career | |
| Fields | |
| Institutions | University of Copenhagen |
Jens Juul Holst (born 31 August 1945)[1] is a Danish physician and physiologist. He is known for discovering and describing the hormone glucagon-like peptide-1 (GLP-1), a hormone in the gut that plays an important role in the onset and development of Type 2 diabetes.[2] In collaboration with researcher and author Arne Astrup, he discovered that GLP-1 acts as a satiety hormone in humans.[3]
In 2020, he was awarded the Warren Alpert Foundation Prize along Daniel J. Drucker and Joel F. Habener.[4] In 2021, he was awarded the Canada Gairdner International Award along Daniel J. Drucker, Joel F. Habener, and Mary-Claire King.[5] He was also awarded the Banting Medal by the American Diabetes Association (ADA).[6] In 2024, he was awarded the Princess of Asturias Awards for Technical and Scientific Research along Daniel J. Drucker, Jeffrey M. Friedman, Joel F. Habener, and Svetlana Mojsov.[7]
In 2024, he received the Tang Prize in the category of "Biopharmaceutical Science",[8] and the BBVA Foundation Frontiers of Knowledge Award in the category "Biology and Biomedicine".[9] In 2025, he received the Breakthrough Prize in Life Sciences alongside Daniel Drucker, Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsen).[10]
